1. What is it?
GHK describes three linked amino acids: glycine, histidine and lysine. Cu indicates that copper is bound to them. This complex has been studied in relation to the activity of fibroblasts, cells involved in producing components of connective tissue. Interest in collagen comes from its importance to skin structure. However, an effect on laboratory-grown cells does not yet describe a visible cosmetic effect in someone using a finished product. [171]
2. Why do people turn to it?
Studies of topical products for skin appearance and condition are closest to practical use. They have assessed skin after laser treatment and a cream containing GHK-Cu and ferments, among other examples. These are specific products and situations, not confirmation of every possible use of the substance. Improved hydration or wrinkle appearance is also not evidence of longer life, organ repair or treatment of a whole-body disease. Each such claim would require different studies. [172] [173]
3. How does it work?
In a classic cultured-fibroblast experiment, GHK-Cu increased collagen production. This helps explain interest but does not establish a cream's effectiveness. Skin has layers, and the whole formulation matters. In a laboratory dish, cells directly contact the substance. Human research must establish useful changes in skin appearance or function and check for unwanted reactions. [171]
4. What do studies actually show?
A study after laser skin resurfacing, published in 2006, was completed by 13 people. It found no clear advantage in objective assessments of redness, wrinkles and overall skin quality, although participants reported greater satisfaction with the product. This shows why subjective satisfaction should be distinguished from measurable improvement. Both kinds of information are useful, but they are not interchangeable. The small number of participants further limits certainty and how widely the findings can be applied. A participant's experience may depend on many aspects of skin care, which is why objective measurements and independent skin assessments also matter. [172]
5. What do we still not know?
Skin studies often examine a finished mixture of ingredients. If hydration or the appearance of wrinkles changes after using such a product, we cannot automatically tell how much of the effect comes from GHK-Cu. Comparisons of appropriately matched formulations and larger participant groups would help. Improvement visible after a few weeks also does not answer whether it lasts after use stops. Results for one cream should not be treated as an assessment of every product containing this ingredient. Different skin problems also need separate investigation: results after laser treatment do not establish the effect on ordinary, undamaged skin. [173] [172]
6. What are the risks?
Skin application must be separated from injections. For injected GHK-Cu, the FDA highlights limited human data and possible immune reactions related to peptide clusters and impurities. Cosmetic research does not assess those risks. A small study with no obvious skin problems cannot detect rare reactions. Safety concerns the specific product, quality and method of use. [174] [172]
7. Is it an approved medicine?
GHK-Cu should not be presented as an approved whole-body rejuvenation treatment. Use as a cosmetic ingredient is not drug approval. The FDA document discussed here addresses possible risks of injected products. It cannot establish identical risk for all GHK-Cu creams, because their uses and safety questions differ. [174] [173]
8. What is new in research?
An August 2026 paper examined a cream combining GHK-Cu with a ferment extract. Its clinical part enrolled 32 people, of whom 30 completed 56 days. Authors described improvements in selected skin features. All participants used the mixture, however, so the effects of GHK-Cu itself were not separated from other ingredients and factors. This is a new lead for cosmetic research, not evidence that injections work. [173]
Where does this information come from?
References link to the publications and documents used. Each source includes its material type and what was reviewed; findings concern the substance, form and study population described.
Show sources and how they were checked
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+
Cell-culture study; 10.10.1988; PubMed abstract read · DOI: 10.1016/0014-5793(88)80509-x. Accessed: 03.11.2026.
- Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin
Small clinical study after laser treatment; July–August 2006; full PubMed abstract reviewed through the search index · DOI: 10.1001/archfaci.8.4.252. Accessed: 3 November 2026.
- Augmented Skin Beneficial Effects of Thermus Thermophilus and Bacillus Subtilis Mixed‐Culture Ferment Extract by Tripeptide GHK‐Cu
Laboratory studies and a small human study of a multi-ingredient cream; 10 August 2026; abstract, methods, results and limitations reviewed from indexed PMC content · DOI: 10.1111/srt.70360. Accessed: 3 November 2026.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks
FDA; page read on 03.11.2026; used the description of risks of injected GHK-Cu and AOD-9604, without drawing conclusions about current compounding eligibility. Accessed: 03.11.2026.